₹15 billion in January-March, but was up 4% quarter-on-quarter due to the ramp up in albuterol. Following the announcement, ICICI Securities in its report said it expects US business, which accounts for 40% of consolidated sales, of the company to gradually improve in the coming quarters with growing contribution from albuterol and from new launches.Never miss a story!